Filter Results:
(14,090)
Show Results For
- All HBS Web
(14,090)
- People (30)
- News (3,255)
- Research (9,144)
- Events (63)
- Multimedia (285)
- Faculty Publications (7,406)
Show Results For
- All HBS Web
(14,090)
- People (30)
- News (3,255)
- Research (9,144)
- Events (63)
- Multimedia (285)
- Faculty Publications (7,406)
- 2024
- Working Paper
Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
This case history describes the development of three generations of cephalosporins – antibiotics that have significantly reduced hospital infections. Specifically, we chronicle how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-133, July 2020. (Revised May 2024.)
- October 2024
- Case
Tonik
By: Andy Wu, Maliha Malek Quadir and Aticus Peterson
This case study examines Tonik, the first digital bank in the Philippines, as it navigates the challenges of scaling its lending operations and achieving profitability in an evolving fintech landscape. It explores Tonik's journey from its launch in 2018 to early 2024,... View Details
- October 2017
- Article
Progress In Interoperability: Measuring US Hospitals' Engagement In Sharing Patient Data
By: A Jay Holmgren, Vaishali Patel and Julia Adler-Milstein
Achieving an interoperable health care system remains a top US policy priority. Despite substantial efforts to encourage interoperability, the first set of national data in 2014 suggested that hospitals’ engagement levels were low. With 2015 data now available, we... View Details
Keywords: Health; Technology; Electronic Health Records; Health Care and Treatment; Data and Data Sets; Technology Networks; Policy; United States
Holmgren, A Jay, Vaishali Patel, and Julia Adler-Milstein. "Progress In Interoperability: Measuring US Hospitals' Engagement In Sharing Patient Data." Health Affairs 36, no. 10 (October 2017): 1820–1827.
- Winter 2021
- Article
Can Staggered Boards Improve Value? Causal Evidence from Massachusetts
By: Robert Daines, Shelley Xin Li and Charles C.Y. Wang
We study the effect of staggered boards (SBs) using a quasi-experiment: a 1990 law that imposed an SB on all Massachusetts-incorporated firms. The law led to an increase in Tobin's Q, investment in CAPEX and R&D, patents, higher-quality patented innovations, and... View Details
Keywords: Staggered Board; Entrenchment; Life-cycle; Tobin's Q; Innovation; Profitability; Investor Composition; Governing and Advisory Boards; Investment; Innovation and Invention; Institutional Investing; Value
Daines, Robert, Shelley Xin Li, and Charles C.Y. Wang. "Can Staggered Boards Improve Value? Causal Evidence from Massachusetts." Contemporary Accounting Research 38, no. 4 (Winter 2021): 3053–3084.
- 2024
- Working Paper
Scaling Core Earnings Measurement with Large Language Models
By: Matthew Shaffer and Charles CY Wang
We study the application of large language models (LLMs) to the estimation of core earnings, i.e., a firm's persistent profitability from its core business activities. This construct is central to investors' assessments of economic performance and valuations. However,... View Details
Keywords: Large Language Models; AI and Machine Learning; Accounting; Profit; Corporate Disclosure; Analytics and Data Science; Measurement and Metrics
Shaffer, Matthew, and Charles CY Wang. "Scaling Core Earnings Measurement with Large Language Models." Working Paper, November 2024.
- Article
Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry
By: Leemore S. Dafny, Christopher Ody and Matt Schmitt
The analogy between value-based purchasing in pharmaceuticals and the new frontier of alternative payment models for health care providers is relatively straightforward. Insurers are increasingly demanding steep discounts from providers in exchange for inclusion in... View Details
Keywords: Drug Copayment Coupons; Prescription Drug Policy; Health Care and Treatment; Insurance; Cost; Policy; Pharmaceutical Industry
Dafny, Leemore S., Christopher Ody, and Matt Schmitt. "Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry." New England Journal of Medicine 375, no. 21 (November 24, 2016): 2013–2015.
- November 2019
- Supplement
United Technologies Corp.: Are the Parts Worth More Than the Whole?
By: Benjamin C. Esty and Daniel Fisher
After spending more than 50 years creating a diversified industrial conglomerate that Fortune Magazine described as “arguably the most profitable conglomerate in America” in 2014, UTC’s CEO Greg Hayes was under pressure from activist investors (Dan Loeb and Bill... View Details
Keywords: Corporate Strategy; Business Conglomerates; Financial Management; Corporate Governance; Organizational Structure; Diversification; Valuation; Investment Activism; Financial Strategy; Investment Funds; Value Creation; Aerospace Industry; Electronics Industry; Industrial Products Industry; United States
- 23 Sep 2020
- News
Alumni Consider Election Reform; Clubs Explore Parenting by Case Method
New York members, based on research by business executive Katherine Gehl and HBS Professor Michael Porter, detailing how partisan polarization has rendered government ineffective. That research resulted in a... View Details
Keywords: Margie Kelley
- 01 Feb 2002
- News
Holding Steady in the Wild Blue Yonder
The day after Northern Alliance troops rolled into Kabul as the Taliban withdrew without a fight, Secretary of the Air Force James Roche (DBA '72) cautioned CNN's Larry King, "This is going to go on for some time. And we can't be elated... View Details
- Research Summary
Overview
I am currently a Principal or Co-Principal Investigator of five field-based randomized controlled trials, each of which examines the management of lay health workers in developing countries, with an eye toward generating theoretical insights and policy guidance on how... View Details
- April 2001
- Case
Corruption in International Business (B)
By: Robert E. Kennedy and Rafael M. Di Tella
Focuses on efforts to combat corruption. Approaches include international laws, international agreements, efforts by international development organizations, and private efforts by firms and nongovernmental organizations. View Details
Kennedy, Robert E., and Rafael M. Di Tella. "Corruption in International Business (B)." Harvard Business School Case 701-129, April 2001.
- November 2003 (Revised September 2016)
- Case
Creating Global Oil, 1900-1935
By: Geoffrey G. Jones and Daniel Wadhwani
Taught in the elective MBA course entitled The Evolution of Global Business. Examines the development of an international cartel in the oil industry in the 1920s and 1930s. Focuses on the decisions and actions of the leading multinational oil companies—particularly... View Details
Keywords: History; Competition; Multinational Firms and Management; Alliances; Cooperation; Business and Government Relations; Energy Industry
Jones, Geoffrey G., and Daniel Wadhwani. "Creating Global Oil, 1900-1935." Harvard Business School Case 804-089, November 2003. (Revised September 2016.)
- 05 Dec 2017
- Research & Ideas
What We've Learned from 101 Entrepreneurs in Emerging Markets
understanding the factors that govern business growth in emerging markets. Leaders interviewed in 20 countries include Sir Fazle Hasan Abed, founder and chair, of Bangladesh’s BRAC microfinance company;... View Details
Keywords: by Sean Silverthorne
- 2009
- Book
Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure
A best seller in its category, with many printings. It has been recognized by the U.S. Chamber of Commerce as one of the books that made a difference in public policy in 2008. View Details
Herzlinger, Regina. Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure. McGraw-Hill, 2009.
- August 2009 (Revised January 2012)
- Supplement
Pandora: Royalties Kill the Web Radio Star? (B)
By: Robert C. Pozen and Alex Curtis Rosenfeld
Pozen, Robert C., and Alex Curtis Rosenfeld. "Pandora: Royalties Kill the Web Radio Star? (B)." Harvard Business School Supplement 310-027, August 2009. (Revised January 2012.)
- 2022
- Article
Which Corporate ESG News Does the Market React To?
By: George Serafeim and Aaron Yoon
Using a dataset that classifies firm-level ESG news as positive and negative, we examine how stock prices react to different types of ESG news. We analyze 111,020 firm-day observations for 3,126 companies and find that prices react only to issues identified as... View Details
Keywords: ESG; ESG (Environmental, Social, Governance) Performance; ESG Ratings; Social Capital; Environment; Sustainability; CSR; Stock Price; Stock Market Expectations; Materiality; Market Reaction; Environmental Sustainability; Governance; Social Issues; Performance; News
Serafeim, George, and Aaron Yoon. "Which Corporate ESG News Does the Market React To?" Financial Analysts Journal 78, no. 1 (2022): 59–78.
- March 2015 (Revised February 2017)
- Case
Shanghai: GDP Apostasy
By: George Serafeim
Balancing economic growth alongside environmental sustainability and social inclusion was becoming increasingly important in China. The case describes Shanghai's decision to abandon growth of Gross Domestic Product (GDP) as its primary metric of measuring success.... View Details
Keywords: China; Gdp; Measurement; Measurement Problems; Accountability; Sustainability; Sustainable Development; Strategy Execution; Strategy; Balanced Scorecard; Strategy Map; Macroeconomics; Measurement and Metrics; Corporate Accountability; Accounting; Environmental Sustainability; Development Economics; Corporate Governance; Shanghai
Serafeim, George, Rebecca Henderson, and David Freiberg. "Shanghai: GDP Apostasy." Harvard Business School Case 115-042, March 2015. (Revised February 2017.)
- 24 Jan 2017
- First Look
First Look at New Research: January 24, 2017
care. The paper contains an interview with Kaplan and Porter about their experiences with improving the measurement of health care outcomes and cost. Publisher's link:... View Details
Keywords: Sean Silverthorne
- 03 Jul 2018
- What Do You Think?
Should CEO Satya Nadella Cancel Microsoft’s Contract with ICE?
than a yes or no response, particularly in view of his emphasis on organizational culture. For example, Kisiah commented, “Microsoft should not get involved in politics. It does have employees and customers with all types of View Details
- 09 Aug 2010
- Research & Ideas
How to Speed Up Energy Innovation
private sectors. We know that if you can build what the authors of that chapter call an innovative ecosystem, it appears to really accelerate innovation in very productive ways. What's striking about energy innovation to date is that a lot of it has been channeled... View Details